The Efficacy Evaluation of Tamsulosin Treatment for Benign Prostatic Hyperplasia
Niu Yuan-ji
Abstract
Niu Yuan-ji
Abstract
Objective To investigate the efficacy and safety of tamsulosin for benign prostatic hyperplasia(BPH).Methods 30 cases of patients with BPH were selected,who were given tamsulosin 0.2 mg/d,for 4 weeks.Results The clinical onset times are after medication within 48 hours,the patient′s international prostate symptom score,quality of life score,maximum flow rate,residual urine,were significantly different(P0.05)between before and after treatment.Comparison of blood pressure,alanine aminotransferase,creatinine clearance did not change significantly(P0.05).Conclusion Tamsulosin treatment of lower urinary tract symptoms caused by BPH,is safe and effective with few complications,and especially it also has a high cardiovascular safety.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the efficacy and safety of tamsulosin for benign prostatic hyperplasia(BPH).Methods 30 cases of patients with BPH were selected,who were given tamsulosin 0.2 mg/d,for 4 weeks.Results The clinical onset times are after medication within 48 hours,the patient′s international prostate symptom score,quality of life score,maximum flow rate,residual urine,were significantly different(P0.05)between before and after treatment.Comparison of blood pressure,alanine aminotransferase,creatinine clearance did not change significantly(P0.05).Conclusion Tamsulosin treatment of lower urinary tract symptoms caused by BPH,is safe and effective with few complications,and especially it also has a high cardiovascular safety.
Key concepts: Tamsulosin, Medicine, Urology, Hyperplasia, International Prostate Symptom Score, Prostate, Lower urinary tract symptoms, Creatinine